{"cluster": 50, "subcluster": 72, "abstract_summ": "Although there are still several unanswered questions about this infection, we evaluate the potential for international dissemination of this disease via commercial air travel should the outbreak continue.This decision analytical model describes several key epidemiological features of imported coronavirus disease 2019 (COVID-19) cases in Wenzhou, China.A novel human coronavirus, now provisionally called \u2018SARS-CoV-2\u2019, was identified as the cause of this disease, now named \u2018COVID-19\u2019.There is currently an outbreak of pneumonia of unknown aetiology in Wuhan, China.In this review, we describe some currently applied diagnostic approaches, as well as therapeutics and vaccines, to prevent, treat and control further outbreaks of SARS-CoV-2 infection.A novel coronavirus, designated as SARS-CoV-2, first emerged in Wuhan City, Hubei Province, China, in late December 2019.", "title_summ": "Current development of COVID-19 diagnostics, vaccines and therapeuticsEmergence of a novel human coronavirus threatening human healthPneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travelEpidemiological Assessment of Imported Coronavirus Disease 2019 (COVID-19) Cases in the Most Affected City Outside of Hubei Province, Wenzhou, China", "title_abstract_phrases": "Epidemiological Assessment of Imported Coronavirus Disease 2019 (COVID-19) Cases in the Most Affected City Outside of Hubei Province, Wenzhou, ChinaThis decision analytical model describes several key epidemiological features of imported coronavirus disease 2019 (COVID-19) cases in Wenzhou, China.A novel human coronavirus, now provisionally called \u2018SARS-CoV-2\u2019, was identified as the cause of this disease, now named \u2018COVID-19\u2019.Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travelThere is currently an outbreak of pneumonia of unknown aetiology in Wuhan, China.Current development of COVID-19 diagnostics, vaccines and therapeuticsA novel coronavirus, designated as SARS-CoV-2, first emerged in Wuhan City, Hubei Province, China, in late December 2019.Although there are still several unanswered questions about this infection, we evaluate the potential for international dissemination of this disease via commercial air travel should the outbreak continue.Emergence of a novel human coronavirus threatening human healthIn late December 2019, a cluster of patients with \u2018atypical pneumonia\u2019 of unknown etiology was reported in Wuhan, China."}